jain.com

$380M unallocated cash for shareholder returns

Company: TeraWulf

Subject kind
guidance
Statement date
2024-12-25
Promised by
2025-12-31
Promised amount
380000000.0 USD
Current status
outcome unconfirmed

What the later record shows

Outcome not yet confirmed

This expectation depended on the project financing happening. The only shareholder return shown is about $33.3 million of treasury stock purchases in 2025, and no passage says whether $380 million was made available.

“Purchase of treasury stock ( 33,292 ) — Payments of tax withholding related to net share settlements”
2025-08-07 · TeraWulf 10-Q filed 2025-08-08 View cached copy (2026-08-31)Live source ↗

Checked October 22, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

If project financing is accomplished, TeraWulf expects over $380M of unallocated cash available in 2025 to fund shareholder returns.

Source (primary)

terawulf 8-K exhibit (eh240572111_ex9901.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-22)Live source ↗

Quote: “if we accomplish that, we have over $380 million of unallocated cash available next year to fund returns to shareholders”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms terawulf 8-K exhibit (eh240572111_ex9901.htm)

Quote: “if we accomplish that, we have over $380 million of unallocated cash available next year to fund returns to shareholders”

View cached copy (2026-10-22)Live source ↗

Record of changes

October 22, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 22, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.